The vaccination series consists of 3 ready-to-use liqd doses administered orally to infants. 1st dose is administered at 6-12 wk of age & the remaining doses at a min interval of 4 wk between each dose. Do not replace dose if infant spits or regurgitates vaccine, continue to give infant any remaining doses in the series.
Adequate treatment provisions, including epinephrine inj (1:1000) should be available for immediate use should an anaphylactic reaction occur. Administration to patients or their close contacts who are immunocompromised or w/ malignancies & those receiving immunosuppressive therapy; HIV infection. Individuals who have received a blood transfusion including Ig w/in 42 days. Infants w/ active GI illness, chronic diarrhea, growth retardation, history of congenital abdominal disorders or intussusception; acute infections or febrile illness. Pregnancy & lactation. Infants <6 wk.
Sign Out
 2 mL5badf75e-60a7-4ba7-9f06-9faa00d1faac.GIF)
